About Psynthesys, Inc.

About company

We are addressing the Biopharma elephant in the room: Excessively high clinical trial failures set in motion by increasingly complicated Life Science fields. Our first product off the bench promises to significantly lower development costs associated high rates of clinical errors. Use of the system also results in efficiency gains that could lead to an increase success rates for new drugs that would normally end in product failures in early phases of inquiry. Our product empowers key stakeholders to pre-empt clinical trial errors by simplifying complex clinical trial science and processes, delivering specific need-knowledge direct to clinical investigators in the very contexts that protocol knowledge is applied.